These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18935925)

  • 1. What is the role of neoadjuvant chemotherapy in the management of ovarian cancer?
    Schwartz PE
    Oncology (Williston Park); 2008 Sep; 22(10):1118-25; discussion 1130, 1132, 1134. PubMed ID: 18935925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.
    Vergote IB; De Wever I; Decloedt J; Tjalma W; Van Gramberen M; van Dam P
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):31-6. PubMed ID: 10952124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neoadjuvant chemotherapy and ovarian cancer].
    Ray-Coquard I; Saba C; Bachelot T; Méeus P; Mignotte H; Blondet R; Treilleux I; Peix M; Guastalla JP
    Bull Cancer; 2006 Jul; 93(7):669-76. PubMed ID: 16873075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival.
    Schwartz PE; Rutherford TJ; Chambers JT; Kohorn EI; Thiel RP
    Gynecol Oncol; 1999 Jan; 72(1):93-9. PubMed ID: 9889037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
    Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy for advanced ovarian cancer.
    Schwartz PE; Chambers JT; Makuch R
    Gynecol Oncol; 1994 Apr; 53(1):33-7. PubMed ID: 8175019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer.
    Pectasides D; Farmakis D; Koumarianou A
    Oncology; 2005; 68(1):64-70. PubMed ID: 15809522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study.
    Ansquer Y; Leblanc E; Clough K; Morice P; Dauplat J; Mathevet P; Lhommé C; Scherer C; Tigaud JD; Benchaib M; Fourme E; Castaigne D; Querleu D; Dargent D
    Cancer; 2001 Jun; 91(12):2329-34. PubMed ID: 11413522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer.
    Weinberg LE; Rodriguez G; Hurteau JA
    J Surg Oncol; 2010 Mar; 101(4):334-43. PubMed ID: 20187069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer.
    Chang SJ; Bristow RE; Ryu HS
    Ann Surg Oncol; 2012 Dec; 19(13):4059-67. PubMed ID: 22766983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group).
    Wimberger P; Wehling M; Lehmann N; Kimmig R; Schmalfeldt B; Burges A; Harter P; Pfisterer J; du Bois A
    Ann Surg Oncol; 2010 Jun; 17(6):1642-8. PubMed ID: 20165986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical cytoreduction in ovarian cancer.
    McCreath WA; Chi DS
    Oncology (Williston Park); 2004 May; 18(5):645-53, discussion 653-4, 656, 658. PubMed ID: 15209191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neoadjuvant chemotherapy for advanced epithelial ovarian cancer].
    Hatae M; Onishi Y; Nakamura T; Yamamoto H; Kusumoto M; Matsui T; Mihara K; Taniguchi H
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1833-7. PubMed ID: 11729475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.
    Vergote I; De Wever I; Tjalma W; Van Gramberen M; Decloedt J; van Dam P
    Gynecol Oncol; 1998 Dec; 71(3):431-6. PubMed ID: 9887245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neoadjuvant chemotherapy in the treatment of ovarian cancer].
    Lehoczky O
    Orv Hetil; 2005 Sep; 146(38):1951-5. PubMed ID: 16238247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis.
    Bristow RE; Chi DS
    Gynecol Oncol; 2006 Dec; 103(3):1070-6. PubMed ID: 16875720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive surgery in the management of ovarian cancer.
    Schwartz PE
    Oncology (Williston Park); 2008 Aug; 22(9):1025-33; discussion 1033-8, 1041, 1045. PubMed ID: 18777954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
    Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
    Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictors of response to neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
    Yildirim Y; Ertas IE; Dogan A; Gultekin OE; Gultekin E
    J Surg Oncol; 2012 Feb; 105(2):200-5. PubMed ID: 21815151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: survey results from members of the Society of Gynecologic Oncologists.
    Dewdney SB; Rimel BJ; Reinhart AJ; Kizer NT; Brooks RA; Massad LS; Zighelboim I
    Gynecol Oncol; 2010 Oct; 119(1):18-21. PubMed ID: 20673970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.